Editorial: Synergistic therapy for invasive fungal infection
| Published in: | Frontiers in Cellular and Infection Microbiology |
|---|---|
| Main Authors: | Sunil S. Menghani, Deweshri Nandurkar, Nilesh R. Rarokar |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-07-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1227837/full |
Similar Items
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
by: Mehmet S Pepeler, et al.
Published: (2018-09-01)
by: Mehmet S Pepeler, et al.
Published: (2018-09-01)
Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges
by: Nancy N. Vuong, et al.
Published: (2023-04-01)
by: Nancy N. Vuong, et al.
Published: (2023-04-01)
Antifungal effects of andrographolide and its combination with amphotericin B against selected fungal pathogens
by: Gayus Sale Dafur, et al.
Published: (2025-06-01)
by: Gayus Sale Dafur, et al.
Published: (2025-06-01)
Application and evaluation of topical amphotericin B for the treatment of respiratory fungal infections
by: Ning Cui, et al.
Published: (2024-04-01)
by: Ning Cui, et al.
Published: (2024-04-01)
Amphotericin B in the Era of New Antifungals: Where Will It Stand?
by: Karolina Akinosoglou, et al.
Published: (2024-04-01)
by: Karolina Akinosoglou, et al.
Published: (2024-04-01)
Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway
by: Elhabal SF, et al.
Published: (2025-05-01)
by: Elhabal SF, et al.
Published: (2025-05-01)
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India
by: Murugesan Vanathi, et al.
Published: (2022-01-01)
by: Murugesan Vanathi, et al.
Published: (2022-01-01)
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
by: Daniela Baracaldo-Santamaría, et al.
Published: (2022-05-01)
by: Daniela Baracaldo-Santamaría, et al.
Published: (2022-05-01)
Delivery strategies of amphotericin B for invasive fungal infections
by: Xiaochun Wang, et al.
Published: (2021-08-01)
by: Xiaochun Wang, et al.
Published: (2021-08-01)
Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
by: Hu Z, et al.
Published: (2022-09-01)
by: Hu Z, et al.
Published: (2022-09-01)
Fungal infections of the orbit
by: Bipasha Mukherjee, et al.
Published: (2016-01-01)
by: Bipasha Mukherjee, et al.
Published: (2016-01-01)
Invasive fungal rhinosinusitis in patients with diabetes
by: Nishant Raizada, et al.
Published: (2018-09-01)
by: Nishant Raizada, et al.
Published: (2018-09-01)
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)
Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
by: Laís de Almeida Campos, et al.
Published: (2023-01-01)
by: Laís de Almeida Campos, et al.
Published: (2023-01-01)
Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer
by: Gianluca Bossù, et al.
Published: (2022-09-01)
by: Gianluca Bossù, et al.
Published: (2022-09-01)
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
by: Grace Cuddihy, et al.
Published: (2019-02-01)
by: Grace Cuddihy, et al.
Published: (2019-02-01)
Amphotericin B-Silver Hybrid Nanoparticles Help to Unveil the Mechanism of Biological Activity of the Antibiotic: Disintegration of Cell Membranes
by: Sebastian Janik, et al.
Published: (2023-06-01)
by: Sebastian Janik, et al.
Published: (2023-06-01)
Editorial: Immunity to Human Fungal Pathogens: Mechanisms of Host Recognition, Protection, Pathology, and Fungal Interference
by: Steven P. Templeton, et al.
Published: (2018-10-01)
by: Steven P. Templeton, et al.
Published: (2018-10-01)
Fungal Ball Obstructive Uropathy in an Elderly Female with Nil Comorbidity: A Case Report and Review of Literature
by: Vijoy Kumar Jha, et al.
Published: (2021-10-01)
by: Vijoy Kumar Jha, et al.
Published: (2021-10-01)
Refractory fungal infection: Three case reports highlighting good practice
by: Rosemary Barnes, et al.
Published: (2024-12-01)
by: Rosemary Barnes, et al.
Published: (2024-12-01)
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
by: Gustavo A. Niño-Vega, et al.
Published: (2024-12-01)
by: Gustavo A. Niño-Vega, et al.
Published: (2024-12-01)
Frequency and Treatment Outcome of Invasive Fungal Infections in Children with Hematological Malignancies
by: Rabiha Manzoor, et al.
Published: (2025-01-01)
by: Rabiha Manzoor, et al.
Published: (2025-01-01)
Editorial: Molecular Epidemiology of Fungal Infections
by: Min Chen, et al.
Published: (2022-05-01)
by: Min Chen, et al.
Published: (2022-05-01)
Micafungin versus Amphotericin B in treatment of invasive fungal infection in preterm neonates: a randomized control trial
by: Mariam John Amin Ibrahim, et al.
Published: (2025-02-01)
by: Mariam John Amin Ibrahim, et al.
Published: (2025-02-01)
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
by: Célia Faustino, et al.
Published: (2020-01-01)
by: Célia Faustino, et al.
Published: (2020-01-01)
Antifungal Prophylaxis in Solid Organ Transplant Recipients
by: Şebnem ŞENOL, et al.
Published: (2015-12-01)
by: Şebnem ŞENOL, et al.
Published: (2015-12-01)
Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units
by: Yang Q, et al.
Published: (2022-09-01)
by: Yang Q, et al.
Published: (2022-09-01)
Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Pedro Puerta-Alcalde, et al.
Published: (2021-10-01)
by: Pedro Puerta-Alcalde, et al.
Published: (2021-10-01)
Progress in the application of nanoparticles for the treatment of fungal infections: A review
by: Xinlin Zhu, et al.
Published: (2024-01-01)
by: Xinlin Zhu, et al.
Published: (2024-01-01)
High-dose amphotericin: yay or nay? A case series and literature review
by: Kayla R Stover, et al.
Published: (2024-01-01)
by: Kayla R Stover, et al.
Published: (2024-01-01)
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
by: Beatriz Ferreira de Carvalho Patricio, et al.
Published: (2022-12-01)
by: Beatriz Ferreira de Carvalho Patricio, et al.
Published: (2022-12-01)
Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
by: Cheng Zhen, et al.
Published: (2022-06-01)
by: Cheng Zhen, et al.
Published: (2022-06-01)
Evaluation of liposomal amphotericin B for the treatment of fungal keratitis in a tertiary eye care hospital
by: Vishal Kumar, et al.
Published: (2023-01-01)
by: Vishal Kumar, et al.
Published: (2023-01-01)
Tolerability, safety and efficacy of conventional amphotericin B administered by 24-hour infusion to lung transplant receipients
by: A Dutly, et al.
Published: (2002-08-01)
by: A Dutly, et al.
Published: (2002-08-01)
Bronchoscopic instillation of amphotericin B is a safe and effective measure to treat pulmonary mycosis
by: Lei Yang, et al.
Published: (2023-06-01)
by: Lei Yang, et al.
Published: (2023-06-01)
Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis
by: Charul Singh, et al.
Published: (2025-07-01)
by: Charul Singh, et al.
Published: (2025-07-01)
RNAi technology: A Novel approaches against fungal infections
by: Maryam Moazeni, et al.
Published: (2014-08-01)
by: Maryam Moazeni, et al.
Published: (2014-08-01)
Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review
by: Afzal Azim, et al.
Published: (2024-03-01)
by: Afzal Azim, et al.
Published: (2024-03-01)
Editorial: Insights into fungal biology with emphasis on pathogenesis in humans
by: Angel Gonzalez, et al.
Published: (2024-07-01)
by: Angel Gonzalez, et al.
Published: (2024-07-01)
Similar Items
-
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection
by: Mehmet S Pepeler, et al.
Published: (2018-09-01) -
Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges
by: Nancy N. Vuong, et al.
Published: (2023-04-01) -
Antifungal effects of andrographolide and its combination with amphotericin B against selected fungal pathogens
by: Gayus Sale Dafur, et al.
Published: (2025-06-01) -
Application and evaluation of topical amphotericin B for the treatment of respiratory fungal infections
by: Ning Cui, et al.
Published: (2024-04-01) -
Amphotericin B in the Era of New Antifungals: Where Will It Stand?
by: Karolina Akinosoglou, et al.
Published: (2024-04-01)
